Impact of immunomodulatory drugs in treatment of primary myelofibrosis

Abstract

Immunomodulatory drugs (IMiDs) such as thalidomide, lenalidomide and pomalidomide have been recently shown to improve anaemia associated with primary myelofibrosis.

Keywords

• thalidomide
• lenalidomide
• pomalidomide